MedX Health Completes $2 Million Private Placement to Fuel Growth

MedX Health ( (TSE:MDX) ) just unveiled an announcement.

MedX Health Corp. announced the final closing of its non-brokered private placement, raising a total of $2,063,500. The funds will be used to further develop its SIAscopy® on DermSecure® telemedicine platform and expand into the occupational health market. The placement involved issuing 29,478,571 units, each consisting of a common share and a share purchase warrant. Insiders contributed $500,000, and qualified agents received commissions and warrants. This move is expected to bolster MedX’s financial position and support its strategic growth initiatives.

More about MedX Health

MedX Health Corp., based in Ontario, Canada, is a prominent medical device and software company specializing in skin health. Their flagship product, the SIAscopy® on DermSecure® telemedicine platform, utilizes advanced SIAscopy® technology. The company also manufactures products like SIAMETRICS®, SIMSYS®, and MoleMate®, which are hand-held devices designed for non-invasive skin analysis. These products are approved for use in Canada, the U.S., Australia, New Zealand, the European Union, and Turkey.

Average Trading Volume: 112,487

Technical Sentiment Signal: Buy

Current Market Cap: C$23.45M

For detailed information about MDX stock, go to TipRanks’ Stock Analysis page.